日韩一中文字-日韩一中文字幕-日韩淫网-日韩淫网视频-日韩婬乱a一级-日韩影片欧美在线素人

About Us

Tianjin Orilife Biopharma Co.,Ltd.

Tianjin Orilife Biopharma Co.,Ltd. is an enterprise engaged in the research, production, and sales of modified nucleosides, nucleotides, phosphoramidites, nucleic acid drug synthesis carriers, nucleic acid drug delivery carriers, and auxiliary materials for nucleic acid drug synthesis.

  • 50+

    Reaction Kettles

  • 6000kg

    Designed Production Capacity

  • 30Years

    Research and Development Experience

Chief Scientist Dr Zhang Peizhuo
Graduated from Tianjin University with a degree in chemical engineering, obtained a Ph.D. in Medicinal Chemistry from Beijing Medical University, previously worked at the New Drug Development Center of the National Medical Products Administration, awarded a Royal Scholarship to pursue postdoctoral research at King's College London, conducted RNA chemistry research under the guidance of the renowned nucleic acid chemist Professor C.B. Reese. Later held positions as a senior researcher and R&D department manager at the well-known nucleic acid chemical manufacturer Cruachem.
Application Area Orilife provides raw materials for the small nucleic acid drug industry, which has a rich pool of candidate targets, a wide range of indications, and great application potential.
Small nucleic acid drugs are pharmaceuticals composed of artificially chemically synthesized short ribonucleotides, either single-stranded or double-stranded. They act on messenger RNA through the Watson-Crick base pairing principle. Compared to traditional drugs, small nucleic acid drugs have significant advantages in candidate targets, design, specificity, efficacy, and clinical development success rate. Coupled with the maturity of RNAi technology, small nucleic acid drugs are expected to have extensive applications in the fields of oncology and rare diseases, potentially improving the accessibility of medications for rare disease patients.
Customized Product Factory visits are welcomed
We can provide custom synthesis of DNA/RNA monomers, accepting orders from milligram to kilogram quantities.
01 R&D Strength

02 Quality Control

03 Application Area

04 Customized Product

Development History

August 2020
Rianlon and GenePharma collaborate on the project of 'Small Nucleic Acid Drug Raw Materials'.
December 2020
Rianlon Life Sciences Division has been officially established.
13 April 2021
Tianjin Orilife Biopharma Co., Ltd. is established, and Rianlon collaborates with GenePharma to enter the field of small nucleic acid drug raw materials.
30 September 2022
Orilife's nucleic acid monomer pilot development project has passed the acceptance inspection.
December 2022
Orilife’s nucleic acid monomer trial production.
August 2020
December 2020
April 2021
September 2022
December 2022

NEWS

News

  • Company News
  • Industry News
  • Announcements
主站蜘蛛池模板： 一本久道久久综合中文字幕 | 影视先锋av资源站男人 | 久久精品麻豆日日躁夜夜躁 | 成人在线免费网站 | 色宅男午夜电影网站 | 欧美激情一区二区三区中文字幕 | 亚洲国产精品无码中文在线 | 亚洲精品AAA揭晓 | 免费观看的成年网站在线播放 | 成人网站免费观看 | 老司机午夜精品视频播放 | 日本免费视频一区一区 | 老色69久久九九精品高潮 | 午夜三级黄色片 | 国产亚洲福利精品一区 | 风韵人妻丰满熟妇老熟女 | 日本一道无马二区日本道专区 | 四虎影视精品 | 成人全黄三级视频在线观看 | 无码一区二区在线欧洲 | 中文字幕亚洲激情 | 国产午夜精品久久理论片 | 日本又色又爽又黄的A片在线电影 | 天天色爱 | 最近日本免费观看高清视频 | 日产精品视频 | 天天干天天爱天天操 | 无码潮喷A片无码高潮小说 无码成A毛片免费 | 欧美性xxxx交 | 一个人看的www视频高清免费 | 中文字幕精品久久久久人妻红杏1 | 果冻传媒mv国产破解 | 色欲人妻AAAAAAA无码 | 手机上免费看twitch的加速器 | 黄色网址在线免费观看 | 影音先锋电影资源av | 天天射天天干 | 国产亚洲欧美在线观看的 | 伊人久久亚洲精品一区 | 欧美日韩精品一区二区在线线 | 91精品三级在线观看播放 |